NCT01803347View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Anal Fistula
Interventions
DRUG

◦Drug: ASCs. + fibrin glue

Experimental group

DRUG

fibrin glue

•Active Comparator: Fibrin glue Intervention: Drug: Fibrin adhesive

Trial Locations (5)

28046

Hospital Universitario La Paz, Madrid

31008

Clínica Universitaria de Navarra, Pamplona

37007

Hospital Clínico Universitario, Salamanca

46014

Hospital General Universitario, Valencia

59009

Hospital Clínico Lozano Blesa, Zaragoza

All Listed Sponsors
lead

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

OTHER

NCT01803347 - Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells | Biotech Hunter | Biotech Hunter